West Pharmaceutical Services, Inc. (WST) has disclosed a new risk, in the Sales & Marketing category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
West Pharmaceutical Services, Inc. relies heavily on a relatively small group of customers for a substantial portion of its revenue, which heightens vulnerability to any loss of a key account or a significant reduction in orders. This concentration also increases exposure to adverse contract terms, pricing pressure, and operational disruptions, any of which could materially affect its business, financial condition, and operating results.
The average WST stock price target is $321.09, implying 29.34% upside potential.
To learn more about West Pharmaceutical Services, Inc.’s risk factors, click here.